K&L Gates Triage: The Opioid Epidemic: DEA’s Role in Regulating Individuals and Entities Handling Controlled Substances

K&L Gates LLP
Contact

K&L Gates LLP

In the fifth episode of our series on the national opioid crisis, Hilary Bowman discusses the Drug Enforcement Administration’s (DEA) role in regulating individuals and entities handling controlled substances, including opioids. 

Specifically, the episode explains the impact of the Comprehensive Addiction and Recovery Act of 2016 (CARA) and recent rulemaking on access to maintenance and detoxification treatment administered by physicians and midlevel practitioners. The episode also highlights the responsibilities of all DEA registrants to safeguard controlled substances, maintain records, and report suspicious activity to the DEA.  

Triage: Rapid Legal Lessons for Busy Health Care Professionals has been created by K&L Gates to convey information about developments in health law through short, five to ten minute podcasts. Catch-up on past episodes by visiting our Triage program page (http://healthcare-triage.klgates-media.libsynpro.com) or subscribe to Triage via your favorite podcast app to have our episodes delivered directly to you as they become available.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© K&L Gates LLP | Attorney Advertising

Written by:

K&L Gates LLP
Contact
more
less

K&L Gates LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide